Cargando…
Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment
BACKGROUND: Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) may occur as preclinical stages of Alzheimer's disease (AD), ultimately leading to dementia. Glycated hemoglobin A1c (HbA1c) is a diagnostic marker for diabetes mellitus and indicates mortality risk. OBJECTIVES:...
Autores principales: | Dreier, J., Schernhammer, E., Haslacher, H., Stögmann, E., Lehrner, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638249/ https://www.ncbi.nlm.nih.gov/pubmed/37969915 http://dx.doi.org/10.1007/s40200-023-01303-4 |
Ejemplares similares
-
No effect of thyroid hormones on 5‐year mortality in patients with subjective cognitive decline, mild cognitive disorder, and Alzheimer’s disease
por: Đapić, Blaž, et al.
Publicado: (2022) -
Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease using the reliable change index methodology
por: Rosas, Anna Garcia, et al.
Publicado: (2020) -
Differences regarding the five-factor personality model in patients with subjective cognitive decline and mild cognitive impairment
por: Berger-Sieczkowski, Evelyn, et al.
Publicado: (2018) -
Self-reported and informant-reported memory functioning and awareness in patients with mild cognitive impairment and Alzheimer´s disease
por: Silva, Martina Rios, et al.
Publicado: (2016) -
Predictive value of serum adiponectin and hemoglobin levels for vascular cognitive impairment in ischemic stroke patients
por: Li, Zhouling, et al.
Publicado: (2022)